Immunostaining for the monocyte–macrophage marker CD68 revealed that the extent of macrophage infiltration in the LV myocardium was increased in the MetS + HS group compared with the MetS group, and that this effect was attenuated by SAT removal (Fig. 2d, e). This evidence concerns the gene CD68 and metabolic syndrome.